1. Арбеньева Н.С., Чехова Т.А., Братко В.И., Трунов А.Н., Черных В.В. Ретроспективный анализ структуры увеитов (по данным новосибирского филиала МНТК «Микрохирургия глаза») // Практ. медицина. 2017; 2 (9): 25–28.
Arbeneva N.S., Chekhova T.A., Bratko V.I., Trunov A.N., Chernykh V.V. A retrospective analysis of the structure of uveitis (according to the data of the Novosibirsk branch of the MNTK «Eye Microsurgery»). Prakticheskaya meditsina = Practical Medicine. 2017; 2 (9): 25–28. [In Russian].
2. Ачкасов Е.Е., Безуглов Э.Н., Ульянов А.А., Куршев В.В., Репетюк А.Д., Егорова О.Н. Применение аутоплазмы, обогащенной тромбоцитами, в клинической практике. Биомедицина. 2013; (4): 46–59.
Achkasov E.E., Bezuglov E.N., Ulyanov A.A., Kurshev V.V., Repetyuk A.D., Egorova O.N. Application of autoplasma enriched with platelets in clinical practice. Biomeditsina = Biomedicine. 2013; (4): 46–59. [In Russian].
3. Братко В.И., Чехова Т.А., Кулаков А.В., Арбеньева Н.С., Черных В.В., Трунов А.Н. Способ комплексного лечения эндогенного увеита, сопровождающегося макулярным отеком. Пат. 2635083 РФ; Опубл. 08.11.2017.
Bratko V.I., Chekhova T.A., Kulakov A.V., Arbeneva N.S., Chernykh V.V., Trunov A.N. The method of complex treatment of endogenous uveitis, accompanied by macular edema. Patent 2635083 RF; Published 11.08.2017. [In Russian].
4. Дроздова Е.А. Вопросы классификации и эпидемиологии увеитов. РМЖ: Рус. мед. журн. 2016; (3): 155–159.
Drozdova E.A. The classification and epidemiology of uveitis. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2016; (3): 155–159. [In Russian].
5. Дубинина Т.В., Демина А.Б., Эрдес Ш.Ф. HLA-В27-ассоциированные увеиты: эпидемиология, клиническая картина и осложнения. Науч.-практ. ревматология. 2014; (3): 304–310.
6. Dubinina T.V., Demina A.B., Erdes Sh.F. HLA-B27-associated uveitis: epidemiology, clinical picture and complications. Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology. 2014; (3): 304–310. [In Russian].
7. Лыков А.П., Суровцева М.А., Повещенко О.В., Станишевская О.М., Черных Д.В., Арбеньева Н.С., Братко В.И. Лечение идиопатической возрастной макулярной дегенерации аутологичной плазмой, обогащенной лизатом тромбоцитов: проспективное исследование. Вестн. РАМН. 2018; 73 (1): 40–48.
Lykov A.P., Surovtseva M.A., Poveshchenko O.V., Stanishevskaya O.M., Chernykh D.V., Arbeneva N.S., Bratko V.I. Treatment of idiopathic age-related macular degeneration with autologous plasma enriched with platelet lysate: prospective study. Vestnik Rossiyskoy akademii meditsinskikh nauk = Annals of the Russian Academy of Medical Sciences. 2018; 73 (1): 40–48.
8. Трунов А.Н., Арбеньева Н.С., Шваюк А.П., Горбенко О.М., Обухова О.О. Дисбаланс цитокинов в слезной жидкости пациентов с аутоиммунными увеитами // Вестн. ОГУ. 2013; (4): 270–274.
Trunov A.N., Arbeneva N.S., Shvayuk A.P., Gorbenko O.M., Obukhova O.O. Imbalance of cytokines in the tear fluid of patients with autoimmune uveitis. Vestnik Orenburgskogo gosudarstvennogo universiteta = Bulletin of the Orenburg State University. 2013; (4): 270–274. [In Russian].
9. Anitua E., Muruzabal F., de la Fuente M., Merayo-Lloves J., Orive G. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop. Exp. Eye Res. 2014; 119: 27–34.
10. Anitua E., Muruzabal F., Tayebba A., Riestra A., Perez V.L., Merayo-Lloves J., Orive G. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol. 2015; 93 (8): 605–614.
11. Bin Ismail M.A., Lim R.H., Fang H.M., Wong E.P., Ling H.S., Lim W.K., Teoh S.C., Agrawal R. Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)-report 4: analysis and outcome of scleritis in an East Asian population. J. Ophthalmic Inflamm. Infect. 2017; 7 (1): 6.
12. Çakar Özdal M.P., Yazici A., Tüfek M., Öztürk F. Epidemiology of uveitis in a referral hospital in Turkey. Turk. J. Med. Sci. 2014; 44 (2): 337–342.
13. Carreño E., Portero A., Herreras J.M., García-Vázquez C., Whitcup S.M., Stern M.E., Calonge M., Enríquez-de-Salamanca A. Cytokine and chemokine tear levels in patients with uveitis. Acta Ophthalmol. 2017; 95 (5): 405–414.
14. Chen E.J., Bin Ismail M.A., Mi H., Ho S.L., Lim W.K., Teoh S.C., Agrawal R. Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) – Report 1: Epidemiology and classification. Ocul. Immunol. Inflamm. 2016; 6 (5): 1–15.
15. Fardeau C., Champion E., Massamba N. Uveitic macular edema. Eye (Lond). 2016; 30 (10): 1277–1292.
16. Guedes M., Borrego L.M., Proença R.D. Roles of interleukin-17 in uveitis. Indian J. Ophthalmol. 2016; 64 (9): 628–634.
17. Gutteridge I.F., Hall A.J. Acute anterior uveitis in primary care. Clin. Exp. Optom. 2007; 90 (2): 70–82.
18. Jabs D.A., Busingye J. Approach to the diagnosis of the uveitides. Am. J. Ophthalmol. 2013; 156 (2): 228–236.
19. Kim K.M., Shin Y.T., Kim H.K. Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis. Jpn. J. Ophthalmol. 2012; 56 (6): 544–550.
20. Konstantinidis A., Hero M., Nanos P., Panos G.D. Efficacy of autologous platelets in macular hole surgery. Clin. Ophthalmol. 2013; (7): 745–750.
21. Kozak I., Shoughy S.S., Stone D.U. Intravitreal antiangiogenic therapy of uveitic macular edema: A review. J. Ocul. Pharmacol. Ther. 2017; 33 (4): 235–239.
22. Lee R.W., Nicholson L.B., Sen H.N., Chan C.C., Wei L., Nussenblatt R.B., Dick A.D. Autoimmune and autoinflammatory mechanisms in uveitis. Semin. Immunopathol. 2014; 36 (5): 581–594.
23. Lin P. Targeting interleukin-6 for noninfectious uveitis. Clin Ophthalmol. 2015; 11 (9): 1697–1702.
24. Miserocchi E., Fogliato G., Modorati G., Bandello F. Review on the worldwide epidemiology of uveitis. Eur. J. Ophthalmol. 2013; 23 (5): 705–717.
25. Mitkova-Hristova V.T., Konareva-Kostianeva M.I. Macular edema in uveitis. Folia Med. (Plovdiv). 2012; 54 (3): 14–21.
26. Paroli M.P. Retinal complications of juvenile idiopathic arthritis-related uveitis: a microperimetry and optical coherence thomography study. Ocular Immunol. Inflam. 2010; 18 (1): 54–59.
27. Prete M., Dammacco R., Fatone M.C., Racanelli V. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. Clin. Exp. Med. 2016; 16 (2): 125–136.
28. Ronci C., Ferraro A.S., Lanti A., Missiroli F., Sinopoli S., del Proposto G., Cipriani C., de Felici С., Ricci F., Ciotti M., Cudillo L., Arcese W., Adorno G. Platelet-rich plasma as treatment for persistent ocular epithelial defects. Transfus. Apher. Sci. 2015; 52 (3): 300–304.
29. Sun D., Liang D., Kaplan H.J., Shao H. The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU). Cytokine. 2015; 74 (1): 76–80.
30. Thorne J.E., Suhler E., Skup M., Tari S., Macaulay D., Chao J., Ganguli A. Prevalence of noninfectious uveitis in the United States: A claims-based analysis. JAMA Ophthalmol. 2016; 134 (11): 1237–1245.
31. Trusko B., Thorne J., Jabs D., Belfort R., Dick A., Gangaputra S., Nussenblatt R., Okada A., Rosenbaum J. The Standardization of Uveitis Nomenclature (SUN) Project. Development of clinical evidence base utilizing informatics tools and techniques. Methods Inf. Med. 2013; 52 (3): 259–265.